Correlation Between GB Sciences and Adhera Therapeutics
Can any of the company-specific risk be diversified away by investing in both GB Sciences and Adhera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GB Sciences and Adhera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GB Sciences and Adhera Therapeutics, you can compare the effects of market volatilities on GB Sciences and Adhera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GB Sciences with a short position of Adhera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GB Sciences and Adhera Therapeutics.
Diversification Opportunities for GB Sciences and Adhera Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GBLX and Adhera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GB Sciences and Adhera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adhera Therapeutics and GB Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GB Sciences are associated (or correlated) with Adhera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adhera Therapeutics has no effect on the direction of GB Sciences i.e., GB Sciences and Adhera Therapeutics go up and down completely randomly.
Pair Corralation between GB Sciences and Adhera Therapeutics
If you would invest 1.08 in GB Sciences on September 2, 2024 and sell it today you would lose (0.58) from holding GB Sciences or give up 53.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.27% |
| Values | Daily Returns |
GB Sciences vs. Adhera Therapeutics
Performance |
| Timeline |
| GB Sciences |
| Adhera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
GB Sciences and Adhera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GB Sciences and Adhera Therapeutics
The main advantage of trading using opposite GB Sciences and Adhera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GB Sciences position performs unexpectedly, Adhera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adhera Therapeutics will offset losses from the drop in Adhera Therapeutics' long position.| GB Sciences vs. Antibe Therapeutics | GB Sciences vs. Awakn Life Sciences | GB Sciences vs. America Great Health | GB Sciences vs. Therasense |
| Adhera Therapeutics vs. Enveric Biosciences | Adhera Therapeutics vs. Akeso, Inc | Adhera Therapeutics vs. Avax Techs | Adhera Therapeutics vs. Ascletis Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |